A. Butler

发表

[3H] GR67330, a very high affinity ligand for 5-HT3 receptors

Gavin Kilpatrick, R. Hagan, A. Butler, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

The pharmacological characterization of 5‐HT3 receptors in three isolated preparations derived from guinea‐pig tissues

Gavin Kilpatrick, K. Bunce, A. Butler, 1990, British journal of pharmacology.

1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist.

A Butler, Gavin Kilpatrick, A. Oxford, 1990, European journal of pharmacology.

Importance of the C-terminus of the human 5-HT3A receptor subunit

N. Barnes, Terri J. Dover, A. Hope, 2009, Neuropharmacology.

5-Hydroxytryptamine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

G. Martin, J. Hensler, R. Hen, 2019, IUPHAR/BPS Guide to Pharmacology CITE.

Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors

A Butler, J. Hill, A. Butler, 1988, British journal of pharmacology.

Sensory nerve‐mediated relaxation of guinea‐pig isolated pulmonary artery: prejunctional modulation by α2‐adrenoceptor agonists but not sumatriptan

A. Butler, H. Connor, S.P. Worton, 1993, British journal of pharmacology.

5-Hydroxytryptamine receptors in GtoPdb v.2023.1

G. Martin, J. Hensler, B. Roth, 2023, IUPHAR/BPS Guide to Pharmacology CITE.

Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain.

Julia M. Hill, R. Hagan, A. Butler, 1987, European journal of pharmacology.

Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.

David D. Manning, N. Barnes, C. Brady, 2011, Bioorganic & medicinal chemistry letters.